Articles
Sequence Listing Translation: Requirements for Foreign Applications
Navigating the world of international patent filing can be overwhelming, especially when your invention involves biological sequences. If you are a biotechnology researcher, pharmaceutical company, or patent attorney dealing with cross-border filings, understanding sequence listing translation is not optional – it is absolutely essential. A single mistake in your sequence listing submission can delay your patent, lead to rejection, or create costly legal complications. This guide breaks down everything you need to know about sequence listing translation requirements for foreign applications in a clear, practical, and easy-to-understand way.
What Is a Sequence Listing and Why Does Translation Matter?
A sequence listing is a standardized document that describes nucleotide sequences (DNA or RNA) and amino acid sequences (proteins) that form part of a patent application. Whenever a patent application discloses a biological sequence of 10 or more nucleotides or 4 or more amino acids, patent offices around the world require this information to be submitted in a specific, machine-readable format.
When you file a patent in your home country, preparing this document is already a detailed task. But when you expand your patent protection into foreign countries, the challenge multiplies. Sequence listing translation becomes a critical part of your international filing strategy because different countries and regional patent offices have their own rules, languages, and technical standards that must be respected.
The core purpose of sequence listing translation is not just language conversion. It also involves adapting the document to meet jurisdiction-specific formatting standards, ensuring the sequence data is presented accurately, and making sure all free-text fields within the listing are properly translated into the required language.
International Standards Governing Sequence Listing Translation
The foundation of sequence listing translation requirements at the international level comes from WIPO (World Intellectual Property Organization). WIPO has established two key standards that every patent filer must understand:
WIPO Standard ST.25 was the long-standing standard for sequence listings submitted in text-based format (.txt files). For many years, this was the universal requirement for PCT (Patent Cooperation Treaty) applications and most national filings.
WIPO Standard ST.26 replaced ST.25 on July 1, 2022. This newer standard introduced an XML-based format using the ANSI/NISO Z39.96 JATS standard. The shift to ST.26 was a major transformation in how sequence listings are created, submitted, and translated across borders.
Understanding which standard applies to your application is the first step in getting your sequence listing translation right.
Key Requirements for Foreign Sequence Listing Translation
This is the most practical section of this guide. Whether you are filing through the PCT route or directly in a national office, here are the critical requirements you must follow for accurate and compliant sequence listing translation:
Language Requirements by Region
- European Patent Office (EPO): The EPO accepts applications in English, French, and German. Your sequence listing translation must have all free-text portions translated into the official language of your application. The sequence data itself does not change, but annotations, organism names listed in free text, and other descriptive fields must be in the correct language.
- China (CNIPA): Applications filed with the China National Intellectual Property Administration must have the sequence listing translated into Simplified Chinese. The free-text fields, including feature annotations and organism descriptions, must appear in Chinese.
- Japan (JPO): The Japan Patent Office requires sequence listings in Japanese for national phase entries. All textual portions of the sequence listing must be accurately translated and submitted alongside the sequence data.
- South Korea (KIPO): Korean language translation of free-text sections is required for national filings at KIPO.
- United States (USPTO): The USPTO allows sequence listings in English only. If your original filing was in another language, the English translation must be submitted with the national phase entry.
- India (IPO): English is an official patent filing language in India, so sequence listing translation into English is required if the original application was in another language.
Technical Format Requirements
- ST.26 XML files must be validated using the WIPO Sequence software tool before submission.
- The XML structure must not be manually altered during translation, as this can corrupt the file and cause rejection.
- Numeric sequence data, identifiers, and codes must remain identical across all translated versions.
- Free-text qualifiers such as “organism,” “mol_type,” and “note” fields are the primary targets for linguistic sequence listing translation.
- All translated files must carry the same application number and priority information as the original.
Timing and Procedural Compliance
- In PCT applications, sequence listing translation must be submitted at the time of national phase entry, not after.
- Many national offices impose strict deadlines, and late submission of a translated sequence listing can result in the sequences being treated as not disclosed.
- Some countries allow a grace period with a surcharge, but relying on this is risky and not recommended.
Common Mistakes to Avoid in Sequence Listing Translation
Even experienced patent professionals make errors during sequence listing translation for foreign filings. Here are the most frequent pitfalls:
- Translating only the patent description and claims while neglecting the free-text fields in the sequence listing itself.
- Using automated translation tools without expert review, which often produces inaccurate biological or scientific terminology.
- Submitting an ST.25 formatted file to a jurisdiction that now mandates ST.26, or vice versa.
- Failing to validate the XML file after translation edits, leading to corrupted submissions.
- Missing country-specific requirements such as local depositary authority references or region-specific organism naming conventions.
Why Professional Sequence Listing Translation Services Matter
Given the technical and linguistic complexity involved, sequence listing translation is best handled by professionals who understand both the science and the legal requirements. A qualified translation team brings together patent translators with expertise in molecular biology, bioinformatics specialists who understand XML formatting, and legal professionals who monitor jurisdiction-specific updates.
Investing in professional sequence listing translation services protects your intellectual property rights, reduces the risk of rejection, and ensures that your innovation receives the broadest possible protection across global markets. As biotech and pharma industries continue to grow internationally, mastering the requirements of sequence listing translation is no longer just an administrative task. It is a strategic business decision that directly impacts the value and enforceability of your patents worldwide.
We are the leading Patent Sequence Listing Company
At our Sequence Listing Company, we specialize exclusively in creating perfect patent sequence listings for biotechnology and pharmaceutical companies. Founded by patent attorneys and bioinformatics specialists with over 10 years of experience, we understand the critical intersection of scientific innovation and intellectual property protection. Our dedicated team has helped hundreds of companies successfully navigate the complex regulatory requirements of sequence listings across global patent offices. We combine technical precision with regulatory expertise to ensure your valuable innovations receive the protection they deserve without delays or complications.
Our Expertise
- Specialized expertise in WIPO ST.25 and ST.26 standards
- Customized solutions for complex biological sequences
- Guaranteed compliance with patent office requirements
- Rapid 24-48 hour turnaround time
- Comprehensive quality assurance process
Trust Your Patent Sequence Listings to the Industry's Leading Experts
Effectual Services is an award-winning Intellectual Property (IP) management advisory & Consulting firm.
Office
- Suite-427,425 Broadhollow Road Melville | NY-11747